Synthetic method of analogues for emerging infectious disease forecasting.

Publication date: Jun 23, 2025

The Method of Analogues (MOA) has gained popularity in the past decade for infectious disease forecasting due to its non-parametric nature. In MOA, the local behavior observed in a time series is matched to the local behaviors of several historical time series. The known values that directly follow the historical time series that best match the observed time series are used to calculate a forecast. This non-parametric approach leverages historical trends to produce forecasts without extensive parameterization, making it highly adaptable. However, MOA is limited in scenarios where historical data is sparse. This limitation was particularly evident during the early stages of the COVID-19 pandemic, where the emerging global epidemic had little-to-no historical data. In this work, we propose a new method inspired by MOA, called the Synthetic Method of Analogues (sMOA). sMOA replaces historical disease data with a library of synthetic data that describe a broad range of possible disease trends. This model circumvents the need to estimate explicit parameter values by instead matching segments of ongoing time series data to a comprehensive library of synthetically generated segments of time series data. We demonstrate that sMOA has competitive performance with state-of-the-art infectious disease forecasting models, out-performing 78% of models from the COVID-19 Forecasting Hub in terms of averaged Mean Absolute Error and 76% of models from the COVID-19 Forecasting Hub in terms of averaged Weighted Interval Score. Additionally, we introduce a novel uncertainty quantification methodology designed for the onset of emerging epidemics. Developing versatile approaches that do not rely on historical data and can maintain high accuracy in the face of novel pandemics is critical for enhancing public health decision-making and strengthening preparedness for future outbreaks.

Open Access PDF

Concepts Keywords
Decade Analogues
Library Covid
Pandemic Emerging
Popularity Historical
Infectious
Local
Moa
Models
Non
Observed
Parametric
Series
Smoa
Synthetic
Values

Semantics

Type Source Name
disease MESH emerging infectious disease
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH COVID-19 pandemic
drug DRUGBANK Huperzine B
disease MESH uncertainty
drug DRUGBANK Coenzyme M
disease IDO process
disease MESH influenza
drug DRUGBANK Aspartame
pathway REACTOME Reproduction
disease MESH infections
disease IDO infectious agent
disease IDO susceptible population
disease MESH monkeypox
disease MESH Dengue fever
drug DRUGBANK Ranitidine
disease IDO algorithm
disease IDO history
drug DRUGBANK Methionine
drug DRUGBANK Trestolone
drug DRUGBANK L-Valine
disease IDO intervention
drug DRUGBANK Water
disease MESH dengue hemorrhagic fever
pathway KEGG Influenza A

Original Article

(Visited 3 times, 1 visits today)